Genomic correlates of clinical benefits from atezolizumab combined with bevacizumab vs. atezolizumab alone in patients with advanced hepatocellular carcinoma (HCC)

被引：23
|
作者：
Zhu, Andrew X. [1 ,2 ]
Guan, Yinghui [3 ]
Abbas, Alexander R. [3 ]
Koeppen, Hartmut [3 ]
Lu, Shan [3 ]
Hsu, Chih-Hung [4 ]
Lee, Kyung-Hun [5 ]
Lee, Michael S. [6 ]
He, Aiwu Ruth [7 ]
Mahipal, Amit [8 ]
Ding, Beiying [3 ]
Spahn, Jessica [3 ]
Verret, Wendy [3 ]
Ryoo, Baek-Yeol [9 ]
Wang, Yulei [3 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Jiahui Int Canc Ctr, Boston, MA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Seoul Natl Univ, Seoul, South Korea
[6] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[7] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[8] Mayo Clin, Rochester, MN USA
[9] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-CT044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT044
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
    Chon, Young Eun
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kang, Beodeul
    Ha, Yeonjung
    Kim, Do Young
    Hwang, Seong Gyu
    Chon, Hong Jae
    Kim, Beom Kyung
    CANCER MEDICINE, 2023, 12 (03): : 2731 - 2738
  • [32] Organ-specific responses to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma.
    Cheon, Jaekyung
    Jung, Sanghoon
    Kang, Beodeul
    Kim, Hyeyeong
    Kim, Chan
    Chon, Hongjae
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma
    Manfredi, G. F.
    Fulgenzi, C. A. M.
    D'Alessio, A.
    Celsa, C.
    Stefanini, B.
    Cheon, J.
    Ang, C.
    Marron, T. U.
    Saeed, A.
    Wietharn, B.
    Pressiani, T.
    Pinter, M.
    Scheiner, B.
    Huang, Yi-Hsiang
    Phen, S.
    Naqash, A. Rafeh
    Piscaglia, F.
    Lin, R. Po-Ting
    Lin, C. -yen
    Dalbeni, A.
    Vivaldi, C.
    Masi, G.
    Thimme, R.
    Vogel, A.
    Schonlein, M.
    von Felden, J.
    Schulze, K.
    Wege, H.
    Galle, P. R.
    Kudo, M.
    Rimassa, L.
    Singal, A.
    Sharma, R.
    Cortellini, A.
    Chon, H. Jae
    Burlone, M.
    Pirisi, M.
    Pinato, D. J.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S8 - S9
  • [34] Adverse events (AEs) as potential predictive factors of activity in patients with advanced hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (AB)
    Persano, M.
    Rimini, M.
    Tada, T.
    Suda, G.
    Shimose, S.
    Kudo, M.
    Yoo, C.
    Cheon, J.
    Finkelmeier, F.
    Lim, H. Y.
    Presa, J.
    Masi, G.
    Bergamo, F.
    Iavarone, M. A.
    Cabibbo, G.
    Foschi, F. G.
    Piscaglia, F.
    Cascinu, S.
    Scartozzi, M.
    Gardini, A. Casadei
    ANNALS OF ONCOLOGY, 2023, 34 : S1535 - S1535
  • [35] Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
    Merle, Philippe
    Blanc, Jean-Frederic
    Edeline, Julien
    Le Malicot, Karine
    Allaire, Manon
    Assenat, Eric
    Guarssifi, Meriem
    Bouattour, Mohamed
    Peron, Jean-Marie
    Laurent-Puig, Pierre
    Levrero, Massimo
    Costentin, Charlotte
    Guiu, Boris
    Sokol, Harry
    Tougeron, David
    Aparicio, Thomas
    Nault, Jean-Charles
    Phelip, Jean-Marc
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (04) : 464 - 470
  • [36] Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
    Ollivier-Hourmand, Isabelle
    Allaire, Manon
    Cervoni, Jean Paul
    JOURNAL OF HEPATOLOGY, 2022, 77 (02)
  • [37] Atezolizumab and bevacizumab in the treatment of advanced hepatocellular carcinoma - a single-center experience
    Adzic, G.
    Prejac, J.
    Librenjak, N.
    Kekez, D.
    Gorsic, I.
    Plestina, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S115 - S115
  • [38] COST EFFECTIVENESS MODEL OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC) IN FRENCH SETTING
    de Gennes, Dubois C.
    Mazaleyrat, B.
    Alvarez, Sanchez J.
    Lueza, B.
    VALUE IN HEALTH, 2022, 25 (01) : S69 - S69
  • [39] Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Fulgenzi, Claudia A. M.
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Personeni, Nicola
    Pressiani, Tiziana
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    LIVER INTERNATIONAL, 2022, 42 (11) : 2538 - 2547
  • [40] Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
    Scheiner, Bernhard
    Sartoris, Riccardo
    D'Alessio, Antonio
    Fulgenzi, Claudia
    Pomej, Katharina
    Balcar, Lorenz
    Bouattour, Mohamed
    Sidali, Sabrina
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Schulze, Kornelius
    von Felden, Johann
    Hucke, Florian
    Shmanko, Kateryna
    Siebenhuner, Alexander
    Mertens, Joachim C.
    De Dosso, Sara
    Ebert, Matthias
    Teufel, Andreas
    Waldschmidt, Dirk-Thomas
    Radu, Iuliana Pompilia
    Krall, Anja
    Trauner, Michael
    Dufour, Jean-Francois
    Wege, Henning
    Weinmann, Arndt
    Trojan, Joerg
    Stauber, Rudolf E.
    Peck-Radosavljevic, Markus
    Hsu, Wei-Fan
    Vogel, Arndt
    Ronot, Maxime
    Pinato, David J.
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2023, 78 : S491 - S492
12345